<article xmlns="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle http://dtd.nlm.nih.gov/2.0/xsd/archivearticle.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Heart Rhythm</journal-id>
      <journal-title>Heart Rhythm</journal-title>
      <issn pub-type="ppub">1547-5271</issn>
      <issn pub-type="epub">1556-3871</issn>
      <publisher>
        <publisher-name>Elsevier</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">2639647</article-id>
      <article-id pub-id-type="pmid">18456193</article-id>
      <article-id pub-id-type="publisher-id">HRTHM2868</article-id>
      <article-id pub-id-type="doi">10.1016/j.hrthm.2008.01.016</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Cellular bases for human atrial fibrillation</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Workman</surname>
            <given-names>Antony J.</given-names>
          </name>
          <email>A.J.Workman@clinmed.gla.ac.uk</email>
          <xref rid="aff1" ref-type="aff">⁎</xref>
          <xref rid="cor1" ref-type="corresp">⁎</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kane</surname>
            <given-names>Kathleen A.</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">†</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rankin</surname>
            <given-names>Andrew C.</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">⁎</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1">
        <addr-line><sup>⁎</sup>British Heart Foundation Glasgow Cardiovascular Research Centre, Faculty of Medicine, University of Glasgow, Glasgow, United Kingdom</addr-line>
      </aff>
      <aff id="aff2">
        <addr-line><sup>†</sup>Strathclyde Institute of Pharmacy and Biomedical Sciences, Division of Physiology and Pharmacology, University of Strathclyde, Glasgow, United Kingdom.</addr-line>
      </aff>
      <author-notes>
        <corresp id="cor1"><label>⁎</label><bold>Address reprint requests and correspondence:</bold> Dr. Antony J. Workman, British Heart Foundation Glasgow Cardiovascular Research Centre, Faculty of Medicine, University of Glasgow, 126 University Place, Glasgow G12 8TA, United Kingdom. <email>A.J.Workman@clinmed.gla.ac.uk</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>6</month>
        <year>2008</year>
      </pub-date>
      <volume>5</volume>
      <issue>6-2</issue>
      <fpage>S1</fpage>
      <lpage>S6</lpage>
      <history>
        <date date-type="received">
          <day>13</day>
          <month>12</month>
          <year>2007</year>
        </date>
        <date date-type="accepted">
          <day>28</day>
          <month>12</month>
          <year>2007</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Â© 2008 Elsevier Inc..</copyright-statement>
        <copyright-year>2008</copyright-year>
        <copyright-holder>Heart Rhythm Society</copyright-holder>
        <license>
          <p>This document may be redistributed and reused, subject to <ext-link ext-link-type="uri" xlink:href="http://www.elsevier.com/wps/find/authorsview.authors/supplementalterms1.0">certain conditions</ext-link>.</p>
        </license>
      </permissions>
      <abstract>
        <p>Atrial fibrillation (AF) causes substantial morbidity and mortality. It may be triggered and sustained by either reentrant or nonreentrant electrical activity. Human atrial cellular refractory period is shortened in chronic AF, likely aiding reentry. The ionic and molecular mechanisms are not fully understood and may include increased inward rectifier K<sup>+</sup> current and altered Ca<sup>2+</sup> handling. Heart failure, a major cause of AF, may involve arrhythmogenic atrial electrical remodeling, but the pattern is unclear in humans. Beta-blocker therapy prolongs atrial cell refractory period; a potentially antiarrhythmic influence, but the ionic and molecular mechanisms are unclear. The search for drugs to suppress AF without causing ventricular arrhythmias has been aided by basic studies of cellular mechanisms of AF. It remains to be seen whether such drugs will improve patient treatment.</p>
      </abstract>
      <kwd-group>
        <title>Keywords</title>
        <kwd>Arrhythmias (mechanisms)</kwd>
        <kwd>Atrial fibrillation</kwd>
        <kwd>Beta-blocker</kwd>
        <kwd>Electrical remodeling</kwd>
        <kwd>Heart failure</kwd>
        <kwd>Ion current</kwd>
        <kwd>Refractory period</kwd>
        <kwd>Transmembrane action potential</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="sec1">
      <title>Electrophysiological mechanisms of human atrial fibrillation and their study in single atrial cells</title>
      <p>Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia. It causes substantial morbidity and mortality. The majority of atrial premature beats that initiate AF originate from focal ectopic electrical activity in the pulmonary veins (PVs). AF is sustained by single- or multiple- circuit intra-atrial reentry and/or focal ectopy, and the latter may be reentrant or nonreentrant.<xref rid="bib1" ref-type="bibr"><sup>1</sup></xref> Nonreentrant mechanisms include abnormal automaticity (AA) and triggered activity. AA is the premature firing of action potentials (APs) because of abnormal diastolic membrane depolarisation (<xref rid="fig1" ref-type="fig">Figure 1</xref>A) and is favored by, for example, β-adrenergic stimulation or decreased vagal activity. Triggered activity is premature firing due to after-depolarizations. These may be early (EADs), occurring during repolarization and favored by AP prolongation, or delayed (DADs), occurring after an AP and favored by intracellular Ca<sup>2+</sup> overload (<xref rid="fig1" ref-type="fig">Figure 1</xref>A). Reentry is rapid circuitous activation caused by unidirectional conduction block and favored by premature impulses, heterogeneity and shortening of the effective refractory period (ERP), and slowing of conduction velocity, θ (<xref rid="fig1" ref-type="fig">Figure 1</xref>B). Several electrophysiological parameters that may affect AF genesis and maintenance have been measured in human atrial isolated cells. The cellular ERP<xref rid="bib2" ref-type="bibr"><sup>2</sup></xref> and AP maximum upstroke velocity, V<sub>max</sub> (<xref rid="fig1" ref-type="fig">Figure 1</xref>C), contribute to myocardial ERP and θ, respectively, so their reduction could promote reentry by shortening its wavelength, λ (<xref rid="fig1" ref-type="fig">Figure 1</xref>B). Cellular arrhythmic depolarizations (CADs<xref rid="bib3" ref-type="bibr"><sup>3</sup></xref>; <xref rid="fig1" ref-type="fig">Figure 1</xref>D) may represent AA, EADs, or DADs, with potential involvement in nonreentrant mechanisms.</p>
    </sec>
    <sec id="sec2">
      <title>Atrial cellular electrical remodeling in AF</title>
      <p>Atrial myocardial electrical and mechanical activity and structure adapt, or remodel, in response to a variety of diseases and other stimuli. For example, congestive heart failure (CHF) may involve electrical remodeling, atrial dilation, and interstitial fibrosis, each potentially predisposing to AF. Once AF occurs, the rapid atrial rate causes atrial electrical remodeling that promotes AF, so AF is autoperpetuating. In goats, induced AF progressively shortened the atrial ERP and AF interval over 24 hours, which reduced the reentry λ and increased AF vulnerability.<xref rid="bib4" ref-type="bibr"><sup>4</sup></xref> Maximal ERP shortening may precede maximal AF duration, but the ERP shortening contributes to the AF substrate. In our laboratory, a similar ERP shortening was found in atrial cells isolated from patients with chronic AF (<xref rid="fig1" ref-type="fig">Figure 1</xref>C). This was associated with impaired ERP rate adaptation, shortening and triangulation of the AP and no change in V<sub>max</sub>.<xref rid="bib2" ref-type="bibr"><sup>2</sup></xref> The shortened AP permitted full repolarization at the fast rates typically encountered in AF and thus prevented the depolarization of the maximum diastolic potential (MDP), that was observed in sinus rhythm (SR).<xref rid="bib2" ref-type="bibr"><sup>2</sup></xref> This effect on MDP might limit Ca<sup>2+</sup> overload in the remodeled atrium, but the ERP changes favor reentry. The ERP is largely determined by the AP duration (APD), which depends on a delicate balance of inward and outward ion currents flowing through a variety of membrane protein channels, pumps, and exchangers. Therefore, an understanding of the mechanisms of human AF-induced atrial electrical remodeling requires knowledge about precise changes in each of these currents, and their contributions to the AP, in AF.</p>
    </sec>
    <sec id="sec3">
      <title>Potential ionic mechanisms of electrical remodeling in AF</title>
      <p>Many human atrial ion currents have so far been studied in AF; they are shown in <xref rid="tbl1" ref-type="table">Table 1</xref>. The inward rectifier K<sup>+</sup> current (I<sub>K1</sub>) is the main determinant of the resting potential (V<sub>m</sub>). Other currents contribute, including acetylcholine-activated K<sup>+</sup> current (I<sub>KACh</sub>), Na<sup>+</sup>, K<sup>+</sup> pump current (I<sub>p</sub>), and possibly ATP-sensitive K<sup>+</sup> current (I<sub>KATP</sub>). I<sub>K1</sub> and I<sub>KACh</sub> also contribute to terminal repolarization. There is consensus that chronic AF is associated with increased density of I<sub>K1</sub> (<xref rid="tbl1" ref-type="table">Table 1</xref>). Furthermore, despite decreased parasympathetic-regulated I<sub>KACh</sub>, a constitutively active (CA) I<sub>KACh</sub>, not requiring its endogenous agonist, is induced in AF (<xref rid="fig2" ref-type="fig">Figure 2</xref>). A single study on I<sub>p</sub>, from our laboratory, showed no change in AF, and changes in I<sub>KATP</sub> are variable. The reported increases in I<sub>K1</sub> and CA I<sub>KACh</sub> were most prominent (with enhanced inward current) at voltages more negative than the AP voltage range. However, enhanced outward I<sub>K1</sub> has also been reported, within the AP voltage range,<xref rid="bib5 bib6 bib8" ref-type="bibr"><sup>5,6,8</sup></xref> which may contribute to the APD and ERP shortening in AF. Increased I<sub>K1</sub> should also hyperpolarize V<sub>m</sub>; while difficult to ascertain in human atrial isolated cells since the “chunk” isolation method may depolarize them, this has been reported in atrial trabeculae.<xref rid="bib6" ref-type="bibr"><sup>6</sup></xref> The AP fires when depolarization sufficient to drive V<sub>m</sub> to threshold activates inward Na<sup>+</sup> current (I<sub>Na</sub>), causing the regenerative and rapid AP upstroke; the larger I<sub>Na</sub>, the faster V<sub>max</sub>. A single study reported no change in I<sub>Na</sub> density in AF, consistent with V<sub>max</sub> (<xref rid="tbl1" ref-type="table">Table 1</xref>), although its inactivation voltage dependency was altered. Partial, or early, repolarization follows the AP upstroke, via activation of a transient outward K<sup>+</sup> current (I<sub>TO</sub>) and the ultrarapid delayed rectifier K<sup>+</sup> current (I<sub>Kur</sub>). AF consistently and markedly reduced I<sub>TO</sub>, but data for I<sub>Kur</sub> are equivocal (<xref rid="tbl1" ref-type="table">Table 1</xref>). The I<sub>TO</sub> reduction may contribute to AP triangulation in AF, as shown by blocking I<sub>TO</sub> with 4-aminopyridine (4-AP).<xref rid="bib2" ref-type="bibr"><sup>2</sup></xref> However, its contribution to the APD<sub>90</sub> and ERP is unclear since 4-AP also blocks I<sub>Kur</sub>, although mathematical modeling suggested a negligible role.<xref rid="bib34" ref-type="bibr"><sup>34</sup></xref> The AP plateau is maintained by inward, L-type Ca<sup>2+</sup>, current (I<sub>CaL</sub>), which is consistently and markedly reduced in chronic AF (<xref rid="tbl1" ref-type="table">Table 1</xref>), despite increased single-channel open probability.<xref rid="bib35" ref-type="bibr"><sup>35</sup></xref> Such I<sub>CaL</sub> reduction depresses the AP plateau, consistent with acute effects of nifedipine<xref rid="bib2" ref-type="bibr"><sup>2</sup></xref> or simulated I<sub>CaL</sub> reduction,<xref rid="bib34" ref-type="bibr"><sup>34</sup></xref> although its contribution alone to the shortening of the APD<sub>90</sub><xref rid="bib2 bib34" ref-type="bibr"><sup>2,34</sup></xref> or ERP<xref rid="bib2" ref-type="bibr"><sup>2</sup></xref> may be small. Mid/late repolarization results from activation of I<sub>Kur</sub> as well as from the rapid (I<sub>Kr</sub>) and slow (I<sub>KS</sub>) delayed rectifiers, which are balanced by inward Na<sup>+</sup>-Ca<sup>2+</sup> exchange current (I<sub>Na/Ca</sub>) following the [Ca<sup>2+</sup>]<sub>i</sub> transient. I<sub>Na/Ca</sub> also underlies the transient inward current responsible for DADs. However, any role for these currents in human AF remodeling is presently unclear, since data are either equivocal or unavailable (<xref rid="tbl1" ref-type="table">Table 1</xref>). AA results from decreased outward and/or increased inward diastolic currents, including I<sub>Na/Ca</sub> and the “funny” current (I<sub>f</sub>). However, data on I<sub>f</sub> are also lacking.</p>
      <p>Human PV isolated cell electrophysiology has not yet been studied. Chronic atrial tachypacing (AT) in dogs produced APD shortening in PV cells that was qualitatively similar to that in atrial cells and also produced similar changes in I<sub>K1</sub>, I<sub>TO</sub>, and I<sub>CaL</sub>.<xref rid="bib36" ref-type="bibr"><sup>36</sup></xref> However, a current that may be analogous to human CA I<sub>KACh</sub> was increased more strongly in PV cells than in atrial cells, perhaps favoring PV reentry.<xref rid="bib37" ref-type="bibr"><sup>37</sup></xref> The relative importance of reentrant versus nonreentrant activity to PV arrhythmogenesis, either before or after AF remodeling, is unknown.<xref rid="bib1" ref-type="bibr"><sup>1</sup></xref></p>
      <p>Atrial electrical activity is intricately linked with cellular and subcellular Ca<sup>2+</sup> fluxes, particularly via I<sub>Na/Ca</sub>. Intracellular Ca<sup>2+</sup> handling is altered in AF, although human data are sparse. In canine atrial cells, acute AT, analogous to a paroxysm of AF, abruptly increases diastolic [Ca<sup>2+</sup>]<sub>i</sub>, a potential trigger of the remodeling process. Chronic AT, by contrast, markedly decreased the [Ca<sup>2+</sup>]<sub>i</sub> transient amplitude,<xref rid="bib38" ref-type="bibr"><sup>38</sup></xref> perhaps reflecting protection from [Ca<sup>2+</sup>]<sub>i</sub> overload. This may result from a deficient trigger function of the markedly reduced I<sub>CaL</sub>, since sarcoplasmic reticular Ca<sup>2+</sup> content was preserved.<xref rid="bib38" ref-type="bibr"><sup>38</sup></xref> Human AF was associated with a potentially arrhythmogenic increase in the frequency of Ca<sup>2+</sup> sparks and waves.<xref rid="bib39" ref-type="bibr"><sup>39</sup></xref> This may represent sarcoplasmic reticular Ca<sup>2+</sup> leak due to ryanodine receptor hyperphosphorylation.<xref rid="bib40" ref-type="bibr"><sup>40</sup></xref></p>
      <p>Whether the combined ionic changes so far established in human AF can account for the associated AP changes is unclear and will require the aid of mathematical models. One such model suggested that the combined I<sub>K1</sub>, I<sub>TO</sub>, and I<sub>CaL</sub> changes could explain the AP changes,<xref rid="bib34" ref-type="bibr"><sup>34</sup></xref> although in the dog, concurrent [Ca<sup>2+</sup>]<sub>i</sub> changes were required.<xref rid="bib38" ref-type="bibr"><sup>38</sup></xref> Another model suggested a major contribution from the I<sub>K1</sub> increase to the stabilization of reentry.<xref rid="bib41" ref-type="bibr"><sup>41</sup></xref></p>
    </sec>
    <sec id="sec4">
      <title>Potential molecular mechanisms in AF: Genetic and nongenetic</title>
      <p>Many atrial ion current changes in human AF are accompanied by, and often considered to be caused by, altered tissue expression of the ion channel pore-forming α-subunits that carry them, for example, increased Kir2.1 (carries I<sub>K1</sub>) and decreased Kv4.3 (I<sub>TO</sub>).<xref rid="bib11" ref-type="bibr"><sup>11</sup></xref> However, there are some intriguing and controversial exceptions. Protein levels of I<sub>CaL</sub> α-subunits were decreased by 40%–55% in three studies,<xref rid="bib35 bib42 bib43" ref-type="bibr"><sup>35,42,43</sup></xref> in line with I<sub>CaL</sub> reduction, but were unchanged in four others.<xref rid="bib11 bib20 bib21 bib44" ref-type="bibr"><sup>11,20,21,44</sup></xref> Also, despite increased CA I<sub>KACh</sub> in AF (<xref rid="tbl1" ref-type="table">Table 1</xref>), the Kir 3.1 protein level was decreased.<xref rid="bib43" ref-type="bibr"><sup>43</sup></xref> The apparent discrepancies between changes in ion current density and protein expression suggest post-translational modification or altered channel regulation. The magnitude of I<sub>CaL</sub> is influenced by a balance between channel phosphorylation by kinases and dephosphorylation by phosphatases. Chronic AF upregulated phosphatase type-2A-C, reducing I<sub>CaL</sub> without requiring reduced channel protein.<xref rid="bib20" ref-type="bibr"><sup>20</sup></xref> Similarly, induction of CA I<sub>KACh</sub> in human AF resulted from abnormal protein kinase- (PK-) C function<xref rid="bib12" ref-type="bibr"><sup>12</sup></xref> (<xref rid="fig2" ref-type="fig">Figure 2</xref>C).</p>
      <p>AF may be a heritable disorder: positive family history was identified in 5% of patients with AF.<xref rid="bib45" ref-type="bibr"><sup>45</sup></xref> Several genetic mutations have been associated with familial AF, mainly for K<sup>+</sup> channels. Most are gain-of-function mutations, increasing I<sub>Ks</sub>, I<sub>Kr</sub>, or I<sub>K1</sub> and expected to shorten ERP and promote reentry, although an I<sub>Kur</sub> loss-of-function mutation might prolong ERP.<xref rid="bib45" ref-type="bibr"><sup>45</sup></xref> However, such mutations occur in other diseases, for example, dilated cardiomyopathy and long-QT, short-QT, and Brugada syndromes, some of which are comorbidities for AF. Nevertheless, it seems that genetic variants are involved in the pathogenesis of AF in a proportion of cases.</p>
    </sec>
    <sec id="sec5">
      <title>Neurohumoral involvement in AF</title>
      <p>AF can result from a sympathetic/parasympathetic imbalance. Furthermore, neurohumoral activation in CHF, an important cause of AF, increases circulating levels of catecholamines, angiotensin, and endothelin (ET-1). Beta-adrenergic stimulation from catecholamines may promote DADs, by increasing I<sub>CaL</sub> and Ca<sup>2+</sup>-induced Ca<sup>2+</sup> release. AF remodeling potentiated the relative increase in I<sub>CaL</sub> produced by β-stimulation (<xref rid="tbl1" ref-type="table">Table 1</xref>). We demonstrated that ET-1 had no direct effect on I<sub>CaL</sub>, APD, or ERP in human atrial cells. However, it abolished isoproterenol-induced increases in I<sub>CaL</sub>, APD<sub>50</sub>, and CADs (<xref rid="fig1" ref-type="fig">Figure 1</xref>D), with no effect on ERP.<xref rid="bib3" ref-type="bibr"><sup>3</sup></xref> Thus, ET-1 might exert an antiadrenergic antiarrhythmic influence in the atria of patients with CHF. Serotonin (5-HT) is released from platelets aggregating in static blood in fibrillating atria. We demonstrated that 5-HT may be arrhythmogenic in human atrium, by increasing I<sub>CaL</sub> and producing CADs, without affecting ERP.<xref rid="bib33" ref-type="bibr"><sup>33</sup></xref> Atrial remodeling by AF may protect from these effects, however, since they were attenuated in cells from patients with chronic AF<xref rid="bib7" ref-type="bibr"><sup>7</sup></xref> (<xref rid="tbl1" ref-type="table">Table 1</xref>).</p>
    </sec>
    <sec id="sec6">
      <title>Postoperative AF: Is there a predisposing atrial cellular electrophysiological substrate?</title>
      <p>AF is common in patients after cardiac surgery (CS). Post-CS AF is independently predicted by old age, pre-CS AF, and pre-CS P-wave changes. Therefore, pre-CS atrial cellular electrophysiology could influence the propensity for new-onset AF post-CS, which is an issue presently under debate. An early study showed an association between post-CS AF and an enhanced pre-CS I<sub>CaL</sub>,<xref rid="bib18" ref-type="bibr"><sup>18</sup></xref> potentially arrhythmogenic post-CS, when catecholamines are elevated. However, we recently demonstrated, by contrast, that pre-CS I<sub>CaL</sub>, AP parameters, or ERP were not predictive of post-CS AF.<xref rid="bib22" ref-type="bibr"><sup>22</sup></xref> Furthermore, no other ion current that was measured, nor the I<sub>CaL</sub> response to β-stimulation, was different between patients with and without post-CS AF (<xref rid="tbl1" ref-type="table">Table 1</xref>). Some currents remain to be studied, but it appears that the electrically remodeled state caused by chronic AF (<xref rid="tbl1" ref-type="table">Table 1</xref>) is not present pre-CS in the atrial cells of patients who develop new-onset post-CS AF.</p>
    </sec>
    <sec id="sec7">
      <title>Heart failure–induced atrial remodeling</title>
      <p>AF is common in patients with CHF, and left ventricular systolic dysfunction (LVSD) substantially increases the risk of AF. It is unclear whether atrial cellular electrical remodeling, in patients in SR, contributes to this predisposition to AF. The available human data are scarce and inconsistent (<xref rid="tbl1" ref-type="table">Table 1</xref>) and are compounded by inevitable variability in the patients' disease states and drug treatments. Atrial cellular electrical remodeling has been demonstrated in canine models of chronic ventricular tachypacing (VTP)-induced CHF. AF was invariably promoted, but the remodeling pattern differed from AF: atrial ERP was unchanged or increased, I<sub>K1</sub> was not increased, both I<sub>TO</sub> and I<sub>KS</sub> were decreased, I<sub>CaL</sub> was only moderately decreased, and I<sub>Na/Ca</sub> was increased.<xref rid="bib46 bib47" ref-type="bibr"><sup>46,47</sup></xref> The increased I<sub>Na/Ca</sub> might favor a triggered origin of AF in this model. CHF also caused atrial fibrosis, and while the ionic remodeling reversed after ceasing VTP, the fibrosis and AF persistence did not.<xref rid="bib46" ref-type="bibr"><sup>46</sup></xref> Thus, atrial electrical remodeling may contribute to AF genesis but was not necessary for its maintenance in this model. Human CHF or LVSD were associated with variable changes in APD, and cellular ERP has not been studied (<xref rid="tbl1" ref-type="table">Table 1</xref>). Human atrial ionic changes in CHF or LVSD may be expected to differ from those in chronic AF, with decreased I<sub>K1</sub> and increased I<sub>TO</sub>, decreased or unchanged I<sub>CaL</sub>, and a decreased I<sub>CaL</sub> response to β-stimulation so far reported (<xref rid="tbl1" ref-type="table">Table 1</xref>). The pattern may depend on the degree of atrial dilation, which itself may cause ionic remodeling (<xref rid="tbl1" ref-type="table">Table 1</xref>). Moreover, CHF- and AF-induced atrial remodeling interact. In dogs, this interaction was complex, not cumulative: chronic AT, imposed on a CHF-remodeled atrium, caused moderate ERP shortening, I<sub>K1</sub> increase, and I<sub>CaL</sub> decrease but did not further remodel I<sub>TO</sub>, I<sub>KS</sub>, or I<sub>Na/Ca</sub>.<xref rid="bib47" ref-type="bibr"><sup>47</sup></xref> No comparative human atrial data could be found.</p>
    </sec>
    <sec id="sec8">
      <title>Atrial remodeling by chronic drug therapy</title>
      <p>Atrial electrophysiology remodels in response not only to diseases and aging but also to long-term drug treatments; so-called pharmacological remodeling.<xref rid="bib31" ref-type="bibr"><sup>31</sup></xref> This was originally demonstrated in rabbits: treatment with the β<sub>1</sub>-blocker metoprolol caused an adaptational prolongation of the atrial APD, maximally after 6 days.<xref rid="bib48" ref-type="bibr"><sup>48</sup></xref> Beta-blockers are increasingly used to treat AF and HF. We demonstrated that in patients in SR, β<sub>1</sub>-blocker treatment for ≥7 days was independently associated with prolonged atrial cell APD<sub>90</sub> and ERP<xref rid="bib22 bib31" ref-type="bibr"><sup>22,31</sup></xref> (<xref rid="fig3" ref-type="fig">Figure 3</xref>A, <xref rid="fig3" ref-type="fig">3</xref>B), and not with I<sub>CaL</sub>.<xref rid="bib22" ref-type="bibr"><sup>22</sup></xref> The I<sub>TO</sub> was reduced (<xref rid="fig3" ref-type="fig">Figure 3</xref>C), and I<sub>SUS</sub> was unchanged (<xref rid="tbl1" ref-type="table">Table 1</xref>). Preliminary data from our group suggest that the I<sub>TO</sub> reduction does not involve altered voltage dependency or kinetics<xref rid="bib32" ref-type="bibr"><sup>32</sup></xref> or altered ion channel expression<xref rid="bib49" ref-type="bibr"><sup>49</sup></xref> and that I<sub>K1</sub> is also reduced.<xref rid="bib32" ref-type="bibr"><sup>32</sup></xref> Recent subgroup analysis revealed a significant correlation between ERP and atenolol dose (<xref rid="fig3" ref-type="fig">Figure 3</xref>D), suggesting that the ERP prolongation is at least partly caused, directly or indirectly, by the atenolol treatment. Such ERP prolongation might contribute to the antiarrhythmic effects of beta-blockers, although a potentiation by chronic β-blockade of effects of 5-HT on I<sub>CaL</sub> (<xref rid="tbl1" ref-type="table">Table 1</xref>) and CADs<xref rid="bib33" ref-type="bibr"><sup>33</sup></xref> could also oppose them.</p>
    </sec>
    <sec id="sec9">
      <title>How research on cellular bases for human AF is driving new therapeutic strategies</title>
      <p>Traditional ERP-prolonging drugs, which are used to inhibit reentry, act by blocking I<sub>Kr</sub>. This is problematic because I<sub>Kr</sub> exists in the ventricle as well as atrium, which risks ventricular EADs and fibrillation. I<sub>Kur</sub> and I<sub>KACh</sub> are considered to be atrium specific, so their block might prolong ERP in atrium only, depending on secondary ionic effects. However, targeting ion channel regulation may be preferable to ion channel block. Altering the PKC pathway that induces CA I<sub>KACh</sub> in chronic AF<xref rid="bib12" ref-type="bibr"><sup>12</sup></xref> might avoid undesirable effects of inhibiting parasympathetic-regulated I<sub>KACh</sub> on sinoatrial node and bladder. Blocking the phosphatase-induced I<sub>CaL</sub> decrease caused by AF<xref rid="bib20" ref-type="bibr"><sup>20</sup></xref> is another possibility. Moreover, “de-remodeling,” in theory, might be better than such “anti-remodeling” since blocking potentially protective adaptations may be risky. Pharmacological targeting of nonreentrant mechanisms of AF also may be considered.</p>
      <p>AF is a highly complex, multifactorial, and dynamic disorder with differing characteristics and etiologies among individuals. As such, it presents an enormous challenge for the development of drugs for its effective and safe treatment. Current basic research is driving the search for new drugs. Several drugs, including I<sub>Kur</sub> and I<sub>KACh</sub> blockers, are entering clinical trials. It remains to be seen whether they will improve patient treatment.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn id="N0x2200f00N0x2ce9850">
        <p>Antony J. Workman received British Heart Foundation Basic Science Lectureship award BS/06/003.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="bib1">
        <label>1</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wit</surname>
              <given-names>A.L.</given-names>
            </name>
            <name>
              <surname>Boyden</surname>
              <given-names>P.A.</given-names>
            </name>
          </person-group>
          <article-title>Triggered activity and atrial fibrillation</article-title>
          <source>Heart Rhythm</source>
          <year>2007</year>
          <volume>4</volume>
          <fpage>S17</fpage>
          <lpage>S23</lpage>
          <pub-id pub-id-type="pmid">17336878</pub-id>
        </citation>
      </ref>
      <ref id="bib2">
        <label>2</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Workman</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Kane</surname>
              <given-names>K.A.</given-names>
            </name>
            <name>
              <surname>Rankin</surname>
              <given-names>A.C.</given-names>
            </name>
          </person-group>
          <article-title>The contribution of ionic currents to changes in refractoriness of human atrial myocytes associated with chronic atrial fibrillation</article-title>
          <source>Cardiovasc Res</source>
          <year>2001</year>
          <volume>52</volume>
          <fpage>226</fpage>
          <lpage>235</lpage>
          <pub-id pub-id-type="pmid">11684070</pub-id>
        </citation>
      </ref>
      <ref id="bib3">
        <label>3</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Redpath</surname>
              <given-names>C.J.</given-names>
            </name>
            <name>
              <surname>Rankin</surname>
              <given-names>A.C.</given-names>
            </name>
            <name>
              <surname>Kane</surname>
              <given-names>K.A.</given-names>
            </name>
          </person-group>
          <article-title>Anti-adrenergic effects of endothelin on human atrial action potentials are potentially anti-arrhythmic</article-title>
          <source>J Mol Cell Cardiol</source>
          <year>2006</year>
          <volume>40</volume>
          <fpage>717</fpage>
          <lpage>724</lpage>
          <pub-id pub-id-type="pmid">16603181</pub-id>
        </citation>
      </ref>
      <ref id="bib4">
        <label>4</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wijffels</surname>
              <given-names>M.C.E.F.</given-names>
            </name>
            <name>
              <surname>Kirchhof</surname>
              <given-names>C.J.H.J.</given-names>
            </name>
            <name>
              <surname>Dorland</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Atrial fibrillation begets atrial fibrillation</article-title>
          <source>Circulation</source>
          <year>1995</year>
          <volume>92</volume>
          <fpage>1954</fpage>
          <lpage>1968</lpage>
          <pub-id pub-id-type="pmid">7671380</pub-id>
        </citation>
      </ref>
      <ref id="bib5">
        <label>5</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bosch</surname>
              <given-names>R.F.</given-names>
            </name>
            <name>
              <surname>Zeng</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Grammer</surname>
              <given-names>J.B.</given-names>
            </name>
          </person-group>
          <article-title>Ionic mechanisms of electrical remodeling in human atrial fibrillation</article-title>
          <source>Cardiovasc Res</source>
          <year>1999</year>
          <volume>44</volume>
          <fpage>121</fpage>
          <lpage>131</lpage>
          <pub-id pub-id-type="pmid">10615396</pub-id>
        </citation>
      </ref>
      <ref id="bib6">
        <label>6</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dobrev</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Graf</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Wettwer</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>Molecular basis of downregulation of G-protein-coupled inward rectifying K+ current (IK,ACh) in chronic human atrial fibrillation: decrease in GIRK4 mRNA correlates with reduced IK,ACh and muscarinic receptor-mediated shortening of action potentials</article-title>
          <source>Circulation</source>
          <year>2001</year>
          <volume>104</volume>
          <fpage>2551</fpage>
          <lpage>2557</lpage>
          <pub-id pub-id-type="pmid">11714649</pub-id>
        </citation>
      </ref>
      <ref id="bib7">
        <label>7</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pau</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Workman</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Kane</surname>
              <given-names>K.A.</given-names>
            </name>
          </person-group>
          <article-title>Electrophysiological and arrhythmogenic effects of 5-hydroxytryptamine on human atrial cells are reduced in atrial fibrillation</article-title>
          <source>J Mol Cell Cardiol</source>
          <year>2007</year>
          <volume>42</volume>
          <fpage>54</fpage>
          <lpage>62</lpage>
          <pub-id pub-id-type="pmid">16989857</pub-id>
        </citation>
      </ref>
      <ref id="bib8">
        <label>8</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Van Wagoner</surname>
              <given-names>D.R.</given-names>
            </name>
            <name>
              <surname>Pond</surname>
              <given-names>A.L.</given-names>
            </name>
            <name>
              <surname>McCarthy</surname>
              <given-names>P.M.</given-names>
            </name>
          </person-group>
          <article-title>Outward K+ current densities and Kv1.5 expression are reduced in chronic human atrial fibrillation</article-title>
          <source>Circ Res</source>
          <year>1997</year>
          <volume>80</volume>
          <fpage>772</fpage>
          <lpage>781</lpage>
          <pub-id pub-id-type="pmid">9168779</pub-id>
        </citation>
      </ref>
      <ref id="bib9">
        <label>9</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dobrev</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Wettwer</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Kortner</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Human inward rectifier potassium channels in chronic and postoperative atrial fibrillation</article-title>
          <source>Cardiovasc Res</source>
          <year>2002</year>
          <volume>54</volume>
          <fpage>397</fpage>
          <lpage>404</lpage>
          <pub-id pub-id-type="pmid">12062344</pub-id>
        </citation>
      </ref>
      <ref id="bib10">
        <label>10</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dobrev</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Friedrich</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Voigt</surname>
              <given-names>N.</given-names>
            </name>
          </person-group>
          <article-title>The G protein-gated potassium current IK,ACh is constitutively active in patients with chronic atrial fibrillation</article-title>
          <source>Circulation</source>
          <year>2005</year>
          <volume>112</volume>
          <fpage>3697</fpage>
          <lpage>3706</lpage>
          <pub-id pub-id-type="pmid">16330682</pub-id>
        </citation>
      </ref>
      <ref id="bib11">
        <label>11</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gaborit</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Steenman</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Lamirault</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Human atrial ion channel and transporter subunit gene-expression remodeling associated with valvular heart disease and atrial fibrillation</article-title>
          <source>Circulation</source>
          <year>2005</year>
          <volume>112</volume>
          <fpage>471</fpage>
          <lpage>481</lpage>
          <pub-id pub-id-type="pmid">16027256</pub-id>
        </citation>
      </ref>
      <ref id="bib12">
        <label>12</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Voigt</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Friedrich</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Bock</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Differential phosphorylation-dependent regulation of constitutively active and muscarinic receptor-activated IK,ACh channels in patients with chronic atrial fibrillation</article-title>
          <source>Cardiovasc Res</source>
          <year>2007</year>
          <volume>74</volume>
          <fpage>426</fpage>
          <lpage>437</lpage>
          <pub-id pub-id-type="pmid">17362895</pub-id>
        </citation>
      </ref>
      <ref id="bib13">
        <label>13</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Workman</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Kane</surname>
              <given-names>K.A.</given-names>
            </name>
            <name>
              <surname>Rankin</surname>
              <given-names>A.C.</given-names>
            </name>
          </person-group>
          <article-title>Characterisation of the Na, K pump current in atrial cells from patients with and without chronic atrial fibrillation</article-title>
          <source>Cardiovasc Res</source>
          <year>2003</year>
          <volume>59</volume>
          <fpage>593</fpage>
          <lpage>602</lpage>
          <pub-id pub-id-type="pmid">14499860</pub-id>
        </citation>
      </ref>
      <ref id="bib14">
        <label>14</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Balana</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Dobrev</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Wettwer</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>Decreased ATP-sensitive K+ current density during chronic human atrial fibrillation</article-title>
          <source>J Mol Cell Cardiol</source>
          <year>2003</year>
          <volume>35</volume>
          <fpage>1399</fpage>
          <lpage>1405</lpage>
          <pub-id pub-id-type="pmid">14654366</pub-id>
        </citation>
      </ref>
      <ref id="bib15">
        <label>15</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wu</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>C.X.</given-names>
            </name>
            <name>
              <surname>Tang</surname>
              <given-names>Y.H.</given-names>
            </name>
          </person-group>
          <article-title>Changes of IK,ATP current density and allosteric modulation during chronic atrial fibrillation</article-title>
          <source>Chin Med J</source>
          <year>2005</year>
          <volume>118</volume>
          <fpage>1161</fpage>
          <lpage>1166</lpage>
          <pub-id pub-id-type="pmid">16117860</pub-id>
        </citation>
      </ref>
      <ref id="bib16">
        <label>16</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brandt</surname>
              <given-names>M.C.</given-names>
            </name>
            <name>
              <surname>Priebe</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Bohle</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>The ultrarapid and the transient outward K+ current in human atrial fibrillation</article-title>
          <source>J Mol Cell Cardiol</source>
          <year>2000</year>
          <volume>32</volume>
          <fpage>1885</fpage>
          <lpage>1896</lpage>
          <pub-id pub-id-type="pmid">11013132</pub-id>
        </citation>
      </ref>
      <ref id="bib17">
        <label>17</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Grammer</surname>
              <given-names>J.B.</given-names>
            </name>
            <name>
              <surname>Bosch</surname>
              <given-names>R.F.</given-names>
            </name>
            <name>
              <surname>Kuhlkamp</surname>
              <given-names>V.</given-names>
            </name>
          </person-group>
          <article-title>Molecular remodeling of Kv4.3 potassium channels in human atrial fibrillation</article-title>
          <source>J Cardiovasc Electrophysiol</source>
          <year>2000</year>
          <volume>11</volume>
          <fpage>626</fpage>
          <lpage>633</lpage>
          <pub-id pub-id-type="pmid">10868735</pub-id>
        </citation>
      </ref>
      <ref id="bib18">
        <label>18</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Van Wagoner</surname>
              <given-names>D.R.</given-names>
            </name>
            <name>
              <surname>Pond</surname>
              <given-names>A.L.</given-names>
            </name>
            <name>
              <surname>Lamorgese</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Atrial L-type Ca2+ currents and human atrial fibrillation</article-title>
          <source>Circ Res</source>
          <year>1999</year>
          <volume>85</volume>
          <fpage>428</fpage>
          <lpage>436</lpage>
          <pub-id pub-id-type="pmid">10473672</pub-id>
        </citation>
      </ref>
      <ref id="bib19">
        <label>19</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Skasa</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Jungling</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Picht</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>L-type calcium currents in atrial myocytes from patients with persistent and non-persistent atrial fibrillation</article-title>
          <source>Basic Res Cardiol</source>
          <year>2001</year>
          <volume>96</volume>
          <fpage>151</fpage>
          <lpage>159</lpage>
          <pub-id pub-id-type="pmid">11327333</pub-id>
        </citation>
      </ref>
      <ref id="bib20">
        <label>20</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Christ</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Boknik</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Wohrl</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>L-type Ca2+ current downregulation in chronic human atrial fibrillation is associated with increased activity of protein phosphatases</article-title>
          <source>Circulation</source>
          <year>2004</year>
          <volume>110</volume>
          <fpage>2651</fpage>
          <lpage>2657</lpage>
          <pub-id pub-id-type="pmid">15492323</pub-id>
        </citation>
      </ref>
      <ref id="bib21">
        <label>21</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Greiser</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Halaszovich</surname>
              <given-names>C.R.</given-names>
            </name>
            <name>
              <surname>Frechen</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>Pharmacological evidence for altered src kinase regulation of ICa,L in patients with chronic atrial fibrillation</article-title>
          <source>Naunyn-Schmiedeberg's Arch Pharmacol</source>
          <year>2007</year>
          <volume>375</volume>
          <fpage>383</fpage>
          <lpage>392</lpage>
          <pub-id pub-id-type="pmid">17593353</pub-id>
        </citation>
      </ref>
      <ref id="bib22">
        <label>22</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Workman</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Pau</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Redpath</surname>
              <given-names>C.J.</given-names>
            </name>
          </person-group>
          <article-title>Post-operative atrial fibrillation is influenced by beta-blocker therapy but not by pre-operative atrial cellular electrophysiology</article-title>
          <source>J Cardiovasc Electrophysiol</source>
          <year>2006</year>
          <volume>17</volume>
          <fpage>1230</fpage>
          <lpage>1238</lpage>
          <pub-id pub-id-type="pmid">17074009</pub-id>
        </citation>
      </ref>
      <ref id="bib23">
        <label>23</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Koumi</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Arentzen</surname>
              <given-names>C.E.</given-names>
            </name>
            <name>
              <surname>Backer</surname>
              <given-names>C.L.</given-names>
            </name>
          </person-group>
          <article-title>Alterations in muscarinic K+ channel response to acetylcholine and to G protein-mediated activation in atrial myocytes isolated from failing human hearts</article-title>
          <source>Circulation</source>
          <year>1994</year>
          <volume>90</volume>
          <fpage>2213</fpage>
          <lpage>2224</lpage>
          <pub-id pub-id-type="pmid">7955176</pub-id>
        </citation>
      </ref>
      <ref id="bib24">
        <label>24</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Koumi</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>R.L.</given-names>
            </name>
            <name>
              <surname>Sato</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Alterations in ATP-sensitive potassium channel sensitivity to ATP in failing human hearts</article-title>
          <source>Am J Physiol</source>
          <year>1997</year>
          <volume>272</volume>
          <fpage>H1656</fpage>
          <lpage>H1665</lpage>
          <pub-id pub-id-type="pmid">9139948</pub-id>
        </citation>
      </ref>
      <ref id="bib25">
        <label>25</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schreieck</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Y.G.</given-names>
            </name>
            <name>
              <surname>Kalra</surname>
              <given-names>B.</given-names>
            </name>
          </person-group>
          <article-title>Differential rate dependence of action potentials, calcium inward and transient outward current in atrial myocytes of patients with and without heart failure</article-title>
          <source>Circulation</source>
          <year>1998</year>
          <volume>98</volume>
          <fpage>611</fpage>
          <comment>(abstract)</comment>
        </citation>
      </ref>
      <ref id="bib26">
        <label>26</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schreieck</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Overbeck</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Altered transient outward current in human atrial myocytes of patients with reduced left ventricular function</article-title>
          <source>J Cardiovasc Electrophysiol</source>
          <year>2000</year>
          <volume>11</volume>
          <fpage>180</fpage>
          <lpage>192</lpage>
          <pub-id pub-id-type="pmid">10709713</pub-id>
        </citation>
      </ref>
      <ref id="bib27">
        <label>27</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Le Grand</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Hatem</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Deroubaix</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>Depressed transient outward and calcium currents in dilated human atria</article-title>
          <source>Cardiovasc Res</source>
          <year>1994</year>
          <volume>28</volume>
          <fpage>548</fpage>
          <lpage>556</lpage>
          <pub-id pub-id-type="pmid">8181045</pub-id>
        </citation>
      </ref>
      <ref id="bib28">
        <label>28</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mansourati</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Le Grand</surname>
              <given-names>B.</given-names>
            </name>
          </person-group>
          <article-title>Transient outward current in young and adult diseased human atria</article-title>
          <source>Am J Physiol</source>
          <year>1993</year>
          <volume>265</volume>
          <fpage>H1466</fpage>
          <lpage>H1470</lpage>
          <pub-id pub-id-type="pmid">8238436</pub-id>
        </citation>
      </ref>
      <ref id="bib29">
        <label>29</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ouadid</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Albat</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Nargeot</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Calcium currents in diseased human cardiac cells</article-title>
          <source>J Cardiovasc Pharmacol</source>
          <year>1995</year>
          <volume>25</volume>
          <fpage>282</fpage>
          <lpage>291</lpage>
          <pub-id pub-id-type="pmid">7752654</pub-id>
        </citation>
      </ref>
      <ref id="bib30">
        <label>30</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cheng</surname>
              <given-names>T.H.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>F.Y.</given-names>
            </name>
            <name>
              <surname>Wei</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Comparison of calcium-current in isolated atrial myocytes from failing and nonfailing human hearts</article-title>
          <source>Mol Cell Biochem</source>
          <year>1996</year>
          <volume>157</volume>
          <fpage>157</fpage>
          <lpage>162</lpage>
          <pub-id pub-id-type="pmid">8739242</pub-id>
        </citation>
      </ref>
      <ref id="bib31">
        <label>31</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Workman</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Kane</surname>
              <given-names>K.A.</given-names>
            </name>
            <name>
              <surname>Russell</surname>
              <given-names>J.A.</given-names>
            </name>
          </person-group>
          <article-title>Chronic beta-adrenoceptor blockade and human atrial cell electrophysiology: evidence of pharmacological remodelling</article-title>
          <source>Cardiovasc Res</source>
          <year>2003</year>
          <volume>58</volume>
          <fpage>518</fpage>
          <lpage>525</lpage>
          <pub-id pub-id-type="pmid">12798424</pub-id>
        </citation>
      </ref>
      <ref id="bib32">
        <label>32</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marshall</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Rankin</surname>
              <given-names>A.C.</given-names>
            </name>
            <name>
              <surname>Kane</surname>
              <given-names>K.A.</given-names>
            </name>
          </person-group>
          <article-title>Pharmacological remodelling of human atrial K+ currents by chronic beta-blockade</article-title>
          <source>Eur Heart J</source>
          <year>2006</year>
          <volume>27</volume>
          <fpage>30</fpage>
          <comment>(abstract)</comment>
        </citation>
      </ref>
      <ref id="bib33">
        <label>33</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pau</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Workman</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Kane</surname>
              <given-names>K.A.</given-names>
            </name>
          </person-group>
          <article-title>Electrophysiological effects of 5-hydroxytryptamine on isolated human atrial myocytes, and the influence of chronic β-adrenoceptor blockade</article-title>
          <source>Br J Pharmacol</source>
          <year>2003</year>
          <volume>140</volume>
          <fpage>1434</fpage>
          <lpage>1441</lpage>
          <pub-id pub-id-type="pmid">14623763</pub-id>
        </citation>
      </ref>
      <ref id="bib34">
        <label>34</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Garratt</surname>
              <given-names>C.J.</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Role of up-regulation of IK1 in action potential shortening associated with atrial fibrillation in humans</article-title>
          <source>Cardiovasc Res</source>
          <year>2005</year>
          <volume>66</volume>
          <fpage>493</fpage>
          <lpage>502</lpage>
          <pub-id pub-id-type="pmid">15914114</pub-id>
        </citation>
      </ref>
      <ref id="bib35">
        <label>35</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Klein</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Schroder</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Vogler</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>Increased open probability of single cardiac L-type calcium channels in patients with chronic atrial fibrillation: role of phosphatase 2A</article-title>
          <source>Cardiovasc Res</source>
          <year>2003</year>
          <volume>59</volume>
          <fpage>37</fpage>
          <lpage>45</lpage>
          <pub-id pub-id-type="pmid">12829174</pub-id>
        </citation>
      </ref>
      <ref id="bib36">
        <label>36</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cha</surname>
              <given-names>T.J.</given-names>
            </name>
            <name>
              <surname>Ehrlich</surname>
              <given-names>J.R.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>L.</given-names>
            </name>
          </person-group>
          <article-title>Atrial tachycardia remodeling of pulmonary vein cardiomyocytes: comparison with left atrium and potential relation to arrhythmogenesis</article-title>
          <source>Circulation</source>
          <year>2005</year>
          <volume>111</volume>
          <fpage>728</fpage>
          <lpage>735</lpage>
          <pub-id pub-id-type="pmid">15699259</pub-id>
        </citation>
      </ref>
      <ref id="bib37">
        <label>37</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ehrlich</surname>
              <given-names>J.R.</given-names>
            </name>
            <name>
              <surname>Cha</surname>
              <given-names>T.J.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>L.</given-names>
            </name>
          </person-group>
          <article-title>Characterization of a hyperpolarization-activated time-dependent potassium current in canine cardiomyocytes from pulmonary vein myocardial sleeves and left atrium</article-title>
          <source>J Physiol</source>
          <year>2004</year>
          <volume>557</volume>
          <fpage>583</fpage>
          <lpage>597</lpage>
          <pub-id pub-id-type="pmid">15020696</pub-id>
        </citation>
      </ref>
      <ref id="bib38">
        <label>38</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kneller</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Leblanc</surname>
              <given-names>N.</given-names>
            </name>
          </person-group>
          <article-title>Remodeling of Ca2+-handling by atrial tachycardia: evidence for a role in loss of rate-adaptation</article-title>
          <source>Cardiovasc Res</source>
          <year>2002</year>
          <volume>54</volume>
          <fpage>416</fpage>
          <lpage>426</lpage>
          <pub-id pub-id-type="pmid">12062346</pub-id>
        </citation>
      </ref>
      <ref id="bib39">
        <label>39</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hove-Madsen</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Llach</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Bayes-Genis</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Atrial fibrillation is associated with increased spontaneous calcium release from the sarcoplasmic reticulum in human atrial myocytes</article-title>
          <source>Circulation</source>
          <year>2004</year>
          <volume>110</volume>
          <fpage>1358</fpage>
          <lpage>1363</lpage>
          <pub-id pub-id-type="pmid">15313939</pub-id>
        </citation>
      </ref>
      <ref id="bib40">
        <label>40</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vest</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Wehrens</surname>
              <given-names>X.H.T.</given-names>
            </name>
            <name>
              <surname>Reiken</surname>
              <given-names>S.R.</given-names>
            </name>
          </person-group>
          <article-title>Defective cardiac ryanodine receptor regulation during atrial fibrillation</article-title>
          <source>Circulation</source>
          <year>2005</year>
          <volume>111</volume>
          <fpage>2025</fpage>
          <lpage>2032</lpage>
          <pub-id pub-id-type="pmid">15851612</pub-id>
        </citation>
      </ref>
      <ref id="bib41">
        <label>41</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pandit</surname>
              <given-names>S.V.</given-names>
            </name>
            <name>
              <surname>Berenfeld</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Anumonwo</surname>
              <given-names>J.M.B.</given-names>
            </name>
          </person-group>
          <article-title>Ionic determinants of functional reentry in a 2-D model of human atrial cells during simulated chronic atrial fibrillation</article-title>
          <source>Biophys J</source>
          <year>2005</year>
          <volume>88</volume>
          <fpage>3806</fpage>
          <lpage>3821</lpage>
          <pub-id pub-id-type="pmid">15792974</pub-id>
        </citation>
      </ref>
      <ref id="bib42">
        <label>42</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brundel</surname>
              <given-names>B.J.J.M.</given-names>
            </name>
            <name>
              <surname>Van Gelder</surname>
              <given-names>I.C.</given-names>
            </name>
            <name>
              <surname>Henning</surname>
              <given-names>R.H.</given-names>
            </name>
          </person-group>
          <article-title>Gene expression of proteins influencing the calcium homeostasis in patients with persistent and paroxysmal atrial fibrillation</article-title>
          <source>Cardiovasc Res</source>
          <year>1999</year>
          <volume>42</volume>
          <fpage>443</fpage>
          <lpage>454</lpage>
          <pub-id pub-id-type="pmid">10533580</pub-id>
        </citation>
      </ref>
      <ref id="bib43">
        <label>43</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brundel</surname>
              <given-names>B.J.J.M.</given-names>
            </name>
            <name>
              <surname>Van Gelder</surname>
              <given-names>I.C.</given-names>
            </name>
            <name>
              <surname>Henning</surname>
              <given-names>R.H.</given-names>
            </name>
          </person-group>
          <article-title>Ion channel remodeling is related to intraoperative atrial effective refractory periods in patients with paroxysmal and persistent atrial fibrillation</article-title>
          <source>Circulation</source>
          <year>2001</year>
          <volume>103</volume>
          <fpage>684</fpage>
          <lpage>690</lpage>
          <pub-id pub-id-type="pmid">11156880</pub-id>
        </citation>
      </ref>
      <ref id="bib44">
        <label>44</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schotten</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Haase</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Frechen</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>The L-type Ca2+-channel subunits α1C and β2 are not downregulated in atrial myocardium of patients with chronic atrial fibrillation</article-title>
          <source>J Mol Cell Cardiol</source>
          <year>2003</year>
          <volume>35</volume>
          <fpage>437</fpage>
          <lpage>443</lpage>
          <pub-id pub-id-type="pmid">12738226</pub-id>
        </citation>
      </ref>
      <ref id="bib45">
        <label>45</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fatkin</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Otway</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Vandenberg</surname>
              <given-names>J.I.</given-names>
            </name>
          </person-group>
          <article-title>Genes and atrial fibrillation: a new look at an old problem</article-title>
          <source>Circulation</source>
          <year>2007</year>
          <volume>116</volume>
          <fpage>782</fpage>
          <lpage>792</lpage>
          <pub-id pub-id-type="pmid">17698744</pub-id>
        </citation>
      </ref>
      <ref id="bib46">
        <label>46</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cha</surname>
              <given-names>T.J.</given-names>
            </name>
            <name>
              <surname>Ehrlich</surname>
              <given-names>J.R.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>L.</given-names>
            </name>
          </person-group>
          <article-title>Dissociation between ionic remodeling and ability to sustain atrial fibrillation during recovery from experimental congestive heart failure</article-title>
          <source>Circulation</source>
          <year>2004</year>
          <volume>109</volume>
          <fpage>412</fpage>
          <lpage>418</lpage>
          <pub-id pub-id-type="pmid">14718405</pub-id>
        </citation>
      </ref>
      <ref id="bib47">
        <label>47</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cha</surname>
              <given-names>T.J.</given-names>
            </name>
            <name>
              <surname>Ehrlich</surname>
              <given-names>J.R.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>L.</given-names>
            </name>
          </person-group>
          <article-title>Atrial ionic remodeling induced by atrial tachycardia in the presence of congestive heart failure</article-title>
          <source>Circulation</source>
          <year>2004</year>
          <volume>110</volume>
          <fpage>1520</fpage>
          <lpage>1526</lpage>
          <pub-id pub-id-type="pmid">15381657</pub-id>
        </citation>
      </ref>
      <ref id="bib48">
        <label>48</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Raine</surname>
              <given-names>A.E.G.</given-names>
            </name>
            <name>
              <surname>Vaughan Williams</surname>
              <given-names>E.M.</given-names>
            </name>
          </person-group>
          <article-title>Adaptation to prolonged β-blockade of rabbit atrial, Purkinje, and ventricular potentials, and of papillary muscle contraction</article-title>
          <source>Circ Res</source>
          <year>1981</year>
          <volume>48</volume>
          <fpage>804</fpage>
          <lpage>812</lpage>
          <pub-id pub-id-type="pmid">6112074</pub-id>
        </citation>
      </ref>
      <ref id="bib49">
        <label>49</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marshall</surname>
              <given-names>G.E.</given-names>
            </name>
            <name>
              <surname>Tellez</surname>
              <given-names>J.O.</given-names>
            </name>
            <name>
              <surname>Russell</surname>
              <given-names>J.A.</given-names>
            </name>
          </person-group>
          <article-title>Reduction of human atrial ITO by chronic beta blockade is not due to changes in ion channel expression</article-title>
          <source>Proc Physiol Soc</source>
          <year>2007</year>
          <volume>8</volume>
          <fpage>PC20</fpage>
          <comment>(abstract)</comment>
        </citation>
      </ref>
    </ref-list>
  </back>
  <floats-wrap>
    <fig id="fig1">
      <label>Figure 1</label>
      <caption>
        <p>Electrophysiological mechanisms of arrhythmias and their study in human atrial cells. <bold>A:</bold> Representation of premature APs (*) from AA, EADs, or DADs. <bold>B:</bold> Premature impulse divides at functional or anatomical obstacle, blocks at tissue with normal (<italic>left side</italic>), but conducts with short (<italic>right</italic>) ERP and reenters previously inexcitable zone. λ = wavelength; θ = conduction velocity. <bold>C:</bold> Original APs stimulated in an atrial cell from a patient in SR or in AF by conditioning pulses (S<sub>1</sub>) and premature test pulses (S<sub>2</sub>). ERP (↔) = longest S<sub>1</sub>-S<sub>2</sub> failing to produce S<sub>2</sub> response of amplitude &gt;80% of S<sub>1</sub>. <bold>D:</bold> Original APs stimulated by a pulse train in the presence of 0.05 μM isoproterenol (ISO), producing CADs (•). The * may represent AA. Panels C and D are based on data in references 2 and 3 with permission from Elsevier.</p>
      </caption>
      <graphic xlink:href="gr1"/>
    </fig>
    <fig id="fig2">
      <label>Figure 2</label>
      <caption>
        <p>Induction of constitutively active acetylcholine-activated K<sup>+</sup> current, CA I<sub>KACh</sub>, in human AF. Single-channel I<sub>K1</sub> and CA I<sub>KACh</sub> currents (<bold>A</bold>) and mean (±standard error) open probabilities (<bold>B</bold>), recorded at −120 mV in atrial cells from patients in SR (open symbols) and AF (solid symbols). *<italic>P</italic> &lt;.05 versus SR. <bold>C:</bold> Potential signaling mechanism of increased CA I<sub>KACh</sub> in AF. In SR, I<sub>KACh</sub> may require channel phosphorylation by calmodulin-dependent PK II (CaMKII), PKG, and PKC.<xref rid="bib12" ref-type="bibr"><sup>12</sup></xref> In AF, CA I<sub>KACh</sub> may result from upregulation of PKCϵ.<xref rid="bib12" ref-type="bibr"><sup>12</sup></xref> Panels A and B are based on data in reference 10 with permission from Lippincott Williams &amp; Wilkins.</p>
      </caption>
      <graphic xlink:href="gr2"/>
    </fig>
    <fig id="fig3">
      <label>Figure 3</label>
      <caption>
        <p>Pharmacological remodeling of human atrial cell electrophysiology by β<sub>1</sub>-blocker therapy. <bold>A:</bold> APs and ERP (↔); <bold>B:</bold> mean (±standard error) APD at 50% and 90% repolarization (APD<sub>50</sub> and APD<sub>90</sub>) and ERP; <bold>C:</bold> transient outward K<sup>+</sup> currents, recorded in single atrial myocytes from patients in SR, treated with a β<sub>1</sub>-blocker ≥7 days (solid symbols) versus those in SR who were not treated with a β-blocker (open symbols). *<italic>P</italic> &lt;.05 versus non β-blocker. <bold>D:</bold> Correlation between atrial cell ERP and patient's atenolol dose/body weight. Heart rate ≤75 bpm. <italic>Dashed lines</italic> indicate the 95% confidence interval. Panels A and C are based on data in reference 31 with permission from Elsevier.</p>
      </caption>
      <graphic xlink:href="gr3"/>
    </fig>
    <table-wrap position="float" id="tbl1">
      <label>Table 1</label>
      <caption>
        <p>Human atrial cellular electrophysiological changes associated with AF, ventricular dysfunction, and drug therapy</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th align="left">Human atrial cell electrophysiological measurement</th>
            <th align="left">Chronic AF</th>
            <th align="left">Post-CS AF</th>
            <th align="left">CHF, LVSD, and/or atrial dilation</th>
            <th align="left">Chronic β<sub>1</sub>-blocker therapy</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td>ERP</td>
            <td>↓<xref rid="bib2" ref-type="bibr"><sup>2</sup></xref></td>
            <td>↔<xref rid="bib22" ref-type="bibr"><sup>22</sup></xref></td>
            <td>NDA</td>
            <td>↑<xref rid="bib3 bib22 bib31" ref-type="bibr"><sup>3,22,31</sup></xref></td>
          </tr>
          <tr>
            <td>APD<sub>90</sub></td>
            <td>↓<xref rid="bib2 bib5 bib6 bib7" ref-type="bibr"><sup>2,5–7</sup></xref></td>
            <td>↔<xref rid="bib22" ref-type="bibr"><sup>22</sup></xref></td>
            <td>↑<xref rid="bib23 bib24" ref-type="bibr"><sup>23,24</sup></xref> ↔<xref rid="bib25 bib26" ref-type="bibr"><sup>25,26</sup></xref></td>
            <td>↑<xref rid="bib22 bib31" ref-type="bibr"><sup>22,31</sup></xref></td>
          </tr>
          <tr>
            <td>APD<sub>50</sub></td>
            <td>↔<xref rid="bib2 bib6" ref-type="bibr"><sup>2,6</sup></xref> ↑<xref rid="bib7" ref-type="bibr"><sup>7</sup></xref></td>
            <td>↔<xref rid="bib22" ref-type="bibr"><sup>22</sup></xref></td>
            <td>↔<xref rid="bib23 bib24" ref-type="bibr"><sup>23,24</sup></xref> ↓<xref rid="bib26" ref-type="bibr"><sup>26</sup></xref></td>
            <td>↔<xref rid="bib3 bib31" ref-type="bibr"><sup>3,31</sup></xref></td>
          </tr>
          <tr>
            <td>AP V<sub>max</sub></td>
            <td>↔<xref rid="bib2" ref-type="bibr"><sup>2</sup></xref></td>
            <td>↔<xref rid="bib22" ref-type="bibr"><sup>22</sup></xref></td>
            <td>NDA</td>
            <td>↔<xref rid="bib31" ref-type="bibr"><sup>31</sup></xref></td>
          </tr>
          <tr>
            <td>I<sub>K1</sub></td>
            <td>↑<xref rid="bib2 bib5 bib6 bib8 bib9 bib10 bib11 bib12" ref-type="bibr"><sup>2,5,6,8–12</sup></xref></td>
            <td>↔<xref rid="bib9 bib22" ref-type="bibr"><sup>9,22</sup></xref></td>
            <td>↓<xref rid="bib23" ref-type="bibr"><sup>23</sup></xref> ↔<xref rid="tblfn1" ref-type="table-fn">⁎</xref><xref rid="bib27" ref-type="bibr"><sup>27</sup></xref></td>
            <td>↓<xref rid="bib32" ref-type="bibr"><sup>32</sup></xref></td>
          </tr>
          <tr>
            <td>I<sub>KACh</sub></td>
            <td>↑<xref rid="bib5" ref-type="bibr"><sup>5</sup></xref> ↓<xref rid="bib6 bib9 bib10 bib12" ref-type="bibr"><sup>6,9,10,12</sup></xref></td>
            <td>↔<xref rid="bib9" ref-type="bibr"><sup>9</sup></xref></td>
            <td>↓<xref rid="bib23" ref-type="bibr"><sup>23</sup></xref></td>
            <td>NDA</td>
          </tr>
          <tr>
            <td>CA I<sub>KACh</sub></td>
            <td>↑<xref rid="bib10 bib12" ref-type="bibr"><sup>10,12</sup></xref></td>
            <td>NDA</td>
            <td>NDA</td>
            <td>NDA</td>
          </tr>
          <tr>
            <td>I<sub>p</sub></td>
            <td>↔<xref rid="bib13" ref-type="bibr"><sup>13</sup></xref></td>
            <td>NDA</td>
            <td>NDA</td>
            <td>NDA</td>
          </tr>
          <tr>
            <td>I<sub>KATP</sub></td>
            <td>↓<xref rid="bib14" ref-type="bibr"><sup>14</sup></xref> ↑<xref rid="bib15" ref-type="bibr"><sup>15</sup></xref></td>
            <td>NDA</td>
            <td>↔<xref rid="bib24" ref-type="bibr"><sup>24</sup></xref></td>
            <td>NDA</td>
          </tr>
          <tr>
            <td>I<sub>Na</sub></td>
            <td>↔<xref rid="bib5" ref-type="bibr"><sup>5</sup></xref></td>
            <td>NDA</td>
            <td>NDA</td>
            <td>NDA</td>
          </tr>
          <tr>
            <td>I<sub>TO</sub></td>
            <td>↓<xref rid="bib2 bib5 bib8 bib16 bib17" ref-type="bibr"><sup>2,5,8,16,17</sup></xref></td>
            <td>↔<xref rid="bib22" ref-type="bibr"><sup>22</sup></xref></td>
            <td>↑<xref rid="bib26" ref-type="bibr"><sup>26</sup></xref> ↓<xref rid="tblfn1" ref-type="table-fn">⁎</xref><xref rid="bib27 bib28" ref-type="bibr"><sup>27,28</sup></xref></td>
            <td>↓<xref rid="bib31 bib32" ref-type="bibr"><sup>31,32</sup></xref></td>
          </tr>
          <tr>
            <td>I<sub>Kur</sub> (I<sub>SUS</sub>)</td>
            <td>↓<xref rid="bib8 bib16" ref-type="bibr"><sup>8,16</sup></xref> ↔<xref rid="bib2 bib5 bib17" ref-type="bibr"><sup>2,5,17</sup></xref></td>
            <td>↔<xref rid="bib22" ref-type="bibr"><sup>22</sup></xref></td>
            <td>↔<xref rid="bib25 bib26" ref-type="bibr"><sup>25,26</sup></xref> ↔<xref rid="tblfn1" ref-type="table-fn">⁎</xref><xref rid="bib28" ref-type="bibr"><sup>28</sup></xref> ↓<xref rid="tblfn1" ref-type="table-fn">⁎</xref><xref rid="bib27" ref-type="bibr"><sup>27</sup></xref></td>
            <td>↔<xref rid="bib31 bib32" ref-type="bibr"><sup>31,32</sup></xref></td>
          </tr>
          <tr>
            <td>I<sub>CaL</sub></td>
            <td>↓<xref rid="bib2 bib5 bib7 bib11 bib18 bib19 bib20 bib21" ref-type="bibr"><sup>2,5,7,11,18–21</sup></xref></td>
            <td>↑<xref rid="bib18" ref-type="bibr"><sup>18</sup></xref> ↔<xref rid="bib22" ref-type="bibr"><sup>22</sup></xref></td>
            <td>↓<xref rid="bib29" ref-type="bibr"><sup>29</sup></xref> ↔<xref rid="bib25 bib30" ref-type="bibr"><sup>25,30</sup></xref> ↓<xref rid="tblfn1" ref-type="table-fn">⁎</xref><xref rid="bib27" ref-type="bibr"><sup>27</sup></xref></td>
            <td>↔<xref rid="bib3 bib7 bib22 bib31 bib33" ref-type="bibr"><sup>3,7,22,31,33</sup></xref></td>
          </tr>
          <tr>
            <td>I<sub>CaL</sub> %↑ by β stimulation</td>
            <td>↑<xref rid="bib18 bib19 bib20 bib21" ref-type="bibr"><sup>18–21</sup></xref></td>
            <td>↔<xref rid="bib22" ref-type="bibr"><sup>22</sup></xref></td>
            <td>↓<xref rid="bib29 bib30" ref-type="bibr"><sup>29,30</sup></xref></td>
            <td>↔<xref rid="bib3 bib22" ref-type="bibr"><sup>3,22</sup></xref></td>
          </tr>
          <tr>
            <td>I<sub>CaL</sub> %↑ by 5-HT</td>
            <td>↓<xref rid="bib7" ref-type="bibr"><sup>7</sup></xref></td>
            <td>NDA</td>
            <td>↓<xref rid="bib29" ref-type="bibr"><sup>29</sup></xref></td>
            <td>↑<xref rid="bib7 bib33" ref-type="bibr"><sup>7,33</sup></xref></td>
          </tr>
          <tr>
            <td>I<sub>Na/Ca</sub>, I<sub>Na/H</sub>, I<sub>Kr</sub>, I<sub>Ks</sub>, I<sub>Cl(swell)</sub>, I<sub>CaB</sub>, I<sub>f</sub></td>
            <td>NDA</td>
            <td>NDA</td>
            <td>NDA</td>
            <td>NDA</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn>
          <p>Arrows show direction of change relative to “controls.”</p>
        </fn>
      </table-wrap-foot>
      <table-wrap-foot>
        <fn id="tblfn1">
          <label>⁎</label>
          <p>= atrial dilation only; NDA = no data available. See text for definitions.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
  </floats-wrap>
</article>